Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review
Girijesh Patel, Josiah Perry, Osama Abdul-Rahim, Arthur Frankel, Daniel Cameron, William Taylor, Rodney Rocconi, Laith Abushahin, Cindy Nelson, Ajay Singh, Moh'D Khushman
Dive into the research topics of 'Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review'. Together they form a unique fingerprint.